Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Providing Real-Time Feedback for Virtual Health

In this new episode of I Don’t Care, host Kevin Stevenson sits down with Mike Telem, the Co-Founder of Kemtai, a groundbreaking computer vision platform, to discuss their unique approach to telemedicine. Founded in 2019, the Israeli-based company has been utilizing technology in healthcare even before the Covid-19 pandemic began. “We’ve developed a computer…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

In this new episode of I Don’t Care, host Kevin Stevenson sits down with Mike Telem, the Co-Founder of Kemtai, a groundbreaking computer vision platform, to discuss their unique approach to telemedicine.

Founded in 2019, the Israeli-based company has been utilizing technology in healthcare even before the Covid-19 pandemic began. “We’ve developed a computer vision exercise platform that can basically provide feedback and guide users in real-time as if a personal trainer or personal physio-therapist trainer was right there with them. We basically turn any device that has a camera into an expert,” said Telem.

Using the instructions to help guide the patient, the software is able to track, monitor and direct the patient based on their performance, adjusting to correct imbalances or maladaptive stances.

As easy as watching a YouTube video, the Kemtai solution combines the convenience of an at-home activity with the insight of a personal trainer.

“This product is all based on software and computer vision and AI,” noted Telem, meaning there are no sensors, logistics, or wearables and any smart device with a camera can use it.

Utilizing the knowledge from real physiotherapist or physical therapists, Kemtai is able to provide users with real-time guidance and feedback.

While the covid-19 pandemic certainly refocused and accelerated the use of telemedicine, most issues require a healthcare professional to be on the other side of the call. In lieu of this, Kemtai uses it’s advanced computer software recognition system which helps patients adhere to their recovery programs and speed up their recovery process. This makes the platform extremely scaleable.

Additionally, the platform can consume any style of movement for particular patients and turn that into an “interactive platform and experience that guides the user, the patient, the member at home even without someone being there.” The software captures and tracks 44 different data points on the human body.

As a B2B platform, Kemtai has recently partnered with virtual physical therapy solution RecoveryOne to provide access to more patients across a range of movement spectrums.

More Like This Story:

Behavioral Health Is Stepping Out of the Shadows of Healthcare

Tearing Down the Barrier of Prior Authorization Through Automation

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512